DHR vs. ABT
Compare and contrast key facts about Danaher Corporation (DHR) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DHR or ABT.
Correlation
The correlation between DHR and ABT is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DHR vs. ABT - Performance Comparison
Loading data...
Key characteristics
DHR:
-0.97
ABT:
1.36
DHR:
-1.37
ABT:
2.09
DHR:
0.82
ABT:
1.26
DHR:
-0.76
ABT:
1.18
DHR:
-1.69
ABT:
7.00
DHR:
18.05%
ABT:
4.30%
DHR:
30.33%
ABT:
21.05%
DHR:
-65.30%
ABT:
-45.66%
DHR:
-36.41%
ABT:
-5.93%
Fundamentals
DHR:
$134.17B
ABT:
$228.79B
DHR:
$5.16
ABT:
$7.70
DHR:
36.33
ABT:
17.08
DHR:
1.84
ABT:
4.17
DHR:
5.63
ABT:
5.40
DHR:
2.64
ABT:
4.69
DHR:
$23.82B
ABT:
$42.34B
DHR:
$14.23B
ABT:
$23.67B
DHR:
$7.17B
ABT:
$11.20B
Returns By Period
In the year-to-date period, DHR achieves a -19.49% return, which is significantly lower than ABT's 17.23% return. Over the past 10 years, DHR has outperformed ABT with an annualized return of 18.00%, while ABT has yielded a comparatively lower 12.57% annualized return.
DHR
-19.49%
-6.00%
-21.54%
-29.07%
-5.76%
6.06%
18.00%
ABT
17.23%
1.12%
12.60%
28.50%
6.96%
9.42%
12.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DHR vs. ABT — Risk-Adjusted Performance Rank
DHR
ABT
DHR vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Danaher Corporation (DHR) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
DHR vs. ABT - Dividend Comparison
DHR's dividend yield for the trailing twelve months is around 0.61%, less than ABT's 1.74% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DHR Danaher Corporation | 0.61% | 0.47% | 0.43% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 36.46% | 0.80% | 0.47% |
ABT Abbott Laboratories | 1.74% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
DHR vs. ABT - Drawdown Comparison
The maximum DHR drawdown since its inception was -65.30%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for DHR and ABT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
DHR vs. ABT - Volatility Comparison
Danaher Corporation (DHR) has a higher volatility of 11.81% compared to Abbott Laboratories (ABT) at 5.52%. This indicates that DHR's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
DHR vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Danaher Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DHR vs. ABT - Profitability Comparison
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.